GNMX holdings
All 59 positions of Corgi Genomics & Precision Medicine ETF. as of Oct 21, 2026issuer data
Positions
59
Top 10 weight
49.0%
Effective holdings
25.2
1 / sum of squared weights
In stocks
97.5%
In bonds
0.0%
Outside the US
6.6%
Asset mix
Sectors
100% of stocks classifiedCountries
Holdings
as of Oct 21, 2026issuer data| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | MRNAModerna, Inc. Common Stock | Equity | 10.77% | $143K | 581 | US |
| 2 | TMOThermo Fisher Scientific, Inc. | Equity | 8.79% | $117K | 168 | US |
| 3 | VRTXVertex Pharmaceuticals Inc | Equity | 5.82% | $77K | 147 | US |
| 4 | ILMNIllumina Inc | Equity | 4.93% | $65K | 231 | US |
| 5 | GHGuardant Health, Inc. Common Stock | Equity | 3.43% | $45K | 273 | US |
| 6 | TXG10x Genomics, Inc. Class A Common Stock | Equity | 3.23% | $43K | 567 | US |
| 7 | GMABGenmab A/S ADS | Equity | 3.18% | $42K | 1,064 | DK |
| 8 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 3.18% | $42K | 217 | US |
| 9 | IOVAIovance Biotherapeutics, Inc. Common Stock | Equity | 3.14% | $42K | 2,849 | US |
| 10 | INCYIncyte Genomics Inc | Equity | 2.52% | $33K | 294 | US |
| 11 | First American Government Obligations Fund 12/01/2031 | Cash | 2.50% | $33K | 33,207 | |
| 12 | TWSTTwist Bioscience Corporation Common Stock | Equity | 2.44% | $32K | 217 | US |
| 13 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 2.38% | $32K | 140 | US |
| 14 | TECHBio-Techne Corp. | Equity | 2.11% | $28K | 385 | US |
| 15 | GRALGRAIL, Inc. Common Stock | Equity | 2.10% | $28K | 210 | US |
| 16 | QGENQIAGEN N.V. | Equity | 2.06% | $27K | 546 | NL |
| 17 | CDNACareDx, Inc. | Equity | 2.02% | $27K | 378 | US |
| 18 | BMRNBioMarin Pharmaceuticals Inc | Equity | 1.84% | $24K | 441 | US |
| 19 | KRYSKrystal Biotech, Inc. Common Stock | Equity | 1.70% | $23K | 70 | US |
| 20 | TEMTempus AI, Inc. Class A Common Stock | Equity | 1.68% | $22K | 329 | US |
| 21 | ADPTAdaptive Biotechnologies Corporation Common Stock | Equity | 1.58% | $21K | 826 | US |
| 22 | CAICaris Life Sciences, Inc. Common Stock | Equity | 1.37% | $18K | 560 | US |
| 23 | NEONeoGenomics, Inc. | Equity | 1.31% | $17K | 1,022 | US |
| 24 | VCYTVeracyte, Inc. | Equity | 1.29% | $17K | 371 | US |
| 25 | ARWRArrowhead Research Corporation | Equity | 1.27% | $17K | 287 | US |
| 26 | CRSPCRISPR Therapeutics AG | Equity | 1.25% | $17K | 329 | US |
| 27 | NRIXNurix Therapeutics, Inc. Common stock | Equity | 1.24% | $16K | 630 | US |
| 28 | PSNLPersonalis, Inc. Common Stock | Equity | 1.19% | $16K | 994 | US |
| 29 | IDYAIDEAYA Biosciences, Inc. Common Stock | Equity | 1.16% | $15K | 434 | US |
| 30 | ABSIAbsci Corporation Common Stock | Equity | 1.15% | $15K | 1,519 | US |
| 31 | SDGRSchrodinger, Inc. Common Stock | Equity | 1.15% | $15K | 637 | US |
| 32 | IONSIonis Pharmaceuticals, Inc. Common Stock | Equity | 1.12% | $15K | 336 | US |
| 33 | RLAYRelay Therapeutics, Inc. Common Stock | Equity | 0.98% | $13K | 707 | US |
| 34 | CERTCertara, Inc. Common Stock | Equity | 0.89% | $12K | 1,155 | US |
| 35 | AZTAAzenta, Inc. | Equity | 0.87% | $12K | 315 | US |
| 36 | BEAMBeam Therapeutics Inc. Common Stock | Equity | 0.84% | $11K | 448 | US |
| 37 | SRPTSarepta Therapeutics,, Inc. Common Stock | Equity | 0.82% | $11K | 588 | US |
| 38 | RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock | Equity | 0.81% | $11K | 2,968 | US |
| 39 | QUREuniQure N.V. | Equity | 0.81% | $11K | 476 | NL |
| 40 | CSTLCastle Biosciences, Inc. Common Stock | Equity | 0.76% | $10K | 294 | US |
| 41 | WGSGeneDx Holdings Corp. Class A Common Stock | Equity | 0.73% | $10K | 140 | US |
| 42 | NTLAIntellia Therapeutics, Inc | Equity | 0.66% | $9K | 749 | US |
| 43 | FDMT4D Molecular Therapeutics, Inc. Common Stock | Equity | 0.63% | $8K | 665 | US |
| 44 | PACBPacific Biosciences of California, Inc. | Equity | 0.60% | $8K | 3,724 | US |
| 45 | GENBGenerate Biomedicines, Inc. Common Stock | Equity | 0.58% | $8K | 588 | US |
| 46 | RAREUltragenyx Pharmaceutical Inc. | Equity | 0.57% | $8K | 476 | US |
| 47 | SOPHSOPHiA GENETICS SA Ordinary Shares | Equity | 0.55% | $7K | 987 | CH |
| 48 | BDSXBiodesix, Inc. Common Stock | Equity | 0.53% | $7K | 294 | US |
| 49 | MYGNMyriad Genetics Inc | Equity | 0.51% | $7K | 1,225 | US |
| 50 | FLGTFulgent Genetics, Inc. Common Stock | Equity | 0.50% | $7K | 329 | US |
| 51 | PRMEPrime Medicine, Inc. Common Stock | Equity | 0.44% | $6K | 1,519 | US |
| 52 | SLDBSolid Biosciences Inc. Common Stock | Equity | 0.43% | $6K | 889 | US |
| 53 | ARCTArcturus Therapeutics Holdings Inc. Common Stock | Equity | 0.42% | $6K | 504 | US |
| 54 | EDITEditas Medicine, Inc. Common Stock | Equity | 0.31% | $4K | 1,638 | US |
| 55 | LABStandard BioTools Inc. Common Stock | Equity | 0.27% | $4K | 5,439 | US |
| 56 | DTILPrecision BioSciences, Inc. Common Stock | Equity | 0.27% | $4K | 525 | US |
| 57 | RCKTRocket Pharmaceuticals, Inc. Common Stock | Equity | 0.25% | $3K | 1,491 | US |
| 58 | CRBUCaribou Biosciences, Inc. Common Stock | Equity | 0.08% | $1K | 1,946 | US |
| 59 | Cash & Other | Cash | -0.02% | −$248 | -248 |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.